HK42394A - Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug - Google Patents

Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug

Info

Publication number
HK42394A
HK42394A HK42394A HK42394A HK42394A HK 42394 A HK42394 A HK 42394A HK 42394 A HK42394 A HK 42394A HK 42394 A HK42394 A HK 42394A HK 42394 A HK42394 A HK 42394A
Authority
HK
Hong Kong
Prior art keywords
dimer
antiviral
ribonuclease
lysozyme
manufacture
Prior art date
Application number
HK42394A
Other languages
English (en)
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of HK42394A publication Critical patent/HK42394A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
HK42394A 1988-05-26 1994-05-05 Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug HK42394A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17858888A 1988-05-26 1988-05-26
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Publications (1)

Publication Number Publication Date
HK42394A true HK42394A (en) 1994-05-13

Family

ID=33162813

Family Applications (1)

Application Number Title Priority Date Filing Date
HK42394A HK42394A (en) 1988-05-26 1994-05-05 Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug

Country Status (23)

Country Link
US (3) US5200182A (da)
EP (1) EP0380484B1 (da)
JP (1) JPH0649659B2 (da)
AT (1) ATE93143T1 (da)
AU (1) AU624331B2 (da)
BG (1) BG60544B1 (da)
CA (1) CA1335425C (da)
CS (1) CS277030B6 (da)
DK (1) DK173078B1 (da)
ES (1) ES2011577A6 (da)
FI (1) FI900412A0 (da)
HK (1) HK42394A (da)
HU (1) HU204710B (da)
IL (1) IL90092A (da)
LV (1) LV10054B (da)
MA (1) MA21560A1 (da)
MW (1) MW390A1 (da)
OA (1) OA09785A (da)
PH (1) PH26284A (da)
RU (1) RU2092183C1 (da)
WO (1) WO1989011294A1 (da)
YU (1) YU109289A (da)
ZA (1) ZA893382B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624331B2 (en) * 1988-05-26 1992-06-11 Nika Health Products Ltd. A composition having as its active ingredient lysozyme or ribonuclease dimer in a pharmaceutically acceptable carrier
JP2732515B2 (ja) * 1990-01-08 1998-03-30 ニカ ヘルス プロダクツ リミテッド リボヌクレアーゼ二量体の製造方法
US5989880A (en) 1990-01-08 1999-11-23 Nika Health Products Ltd. Method of preparing lysozyme dimers
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
DE10210285A1 (de) * 2002-03-08 2003-11-13 Medigene Ag Reversibles Toxin und seine Verwendung
WO2005115477A2 (en) 2004-04-13 2005-12-08 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
JP2009541333A (ja) * 2006-06-23 2009-11-26 クインテセンス バイオサイエンシーズ インコーポレーティッド 修飾リボヌクレアーゼ
EP2049151A4 (en) 2006-07-17 2010-03-24 Quintessence Biosciences Inc METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
WO2008109401A2 (en) * 2007-03-02 2008-09-12 Saint Simeon Lda Composition and method for treating papilloma virus and equine sarcoids
US20100317677A1 (en) * 2007-09-11 2010-12-16 Hassel Bret A Methods of Treating a Microbial Infection by Modulating RNase-L Expression and/or Activity
JP2010540681A (ja) * 2007-10-08 2010-12-24 クインテッセンス バイオサイエンシズ，インコーポレーテッド リボヌクレアーゼに基づく治療のための組成物及び方法
BRPI0920743A2 (pt) 2008-10-01 2016-09-20 Quintessence Biosciences Inc ribonucleases terapeuticas
WO2010099182A1 (en) * 2009-02-25 2010-09-02 Board Of Regents Of The University Of Nebraska Activated creatinine and precursors as antibacterial agents, compositions and products containing such agents and uses thereof
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
EP2457576B1 (en) 2010-11-29 2020-07-08 Eurochit Danuta Kruszewska Lactobacillus reuteri strain for use in the medical and veterinary prophylaxis and treatment of metabolic syndrome or infections
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
RU2509801C2 (ru) * 2012-03-22 2014-03-20 Борис Михайлович Куриненко СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
US20160032413A1 (en) 2012-05-29 2016-02-04 Danuta KRUSZEWSKA Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
RU2504397C1 (ru) * 2012-10-25 2014-01-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
WO2014152678A1 (en) 2013-03-15 2014-09-25 University Of Massachusetts Compositions and methods for delivering agents to the central nervous system
US20170049863A1 (en) * 2014-02-21 2017-02-23 National University Corporation Tokyo University Of Marine Science And Technology Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes
WO2016017784A1 (ja) * 2014-07-31 2016-02-04 キユーピー株式会社 含水流動状組成物及びその製造方法、並びに、リゾチーム加工品及び／又はその塩並びにその製造方法
EP3194425A1 (en) 2014-09-17 2017-07-26 Spogen Biotech Inc. Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
LV15071B (lv) * 2015-07-14 2016-02-20 Rīgas Stradiņa Universitāte Kompozīcija subklīniska mastīta ārstēšanai govīm
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
WO2018123821A1 (ja) 2016-12-28 2018-07-05 Dic株式会社 分散体及びそれを用いたインクジェット用インク組成物、光変換層、及び液晶表示素子
NZ763625A (en) 2017-09-20 2024-07-26 Spogen Biotech Inc Fusion proteins, recombinant bacteria, and exosporium fragments for plant health
US20220273733A1 (en) * 2019-07-26 2022-09-01 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268M (fr) * 1961-06-29 1962-04-24 Puiseux Médicament antimitotique et antiviral.
FR4020M (da) * 1965-01-29 1966-03-21
DE1517751C3 (de) * 1965-07-08 1975-02-27 Eisai Co., Ltd., Tokio Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten
DE1545644A1 (de) * 1965-12-06 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen
GB1110504A (en) * 1966-03-18 1968-04-18 Prodotti Antibiotici Spa Pharmaceutical compositions
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
EP0187705A3 (en) * 1985-01-08 1988-05-11 Norwich Eaton Pharmaceuticals, Inc. Imidazo(4,5-f)quinolines useful as immunomodulating agents
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
AU624331B2 (en) * 1988-05-26 1992-06-11 Nika Health Products Ltd. A composition having as its active ingredient lysozyme or ribonuclease dimer in a pharmaceutically acceptable carrier

Also Published As

Publication number Publication date
JPH0649659B2 (ja) 1994-06-29
DK173078B1 (da) 1999-12-20
ES2011577A6 (es) 1990-01-16
MW390A1 (en) 1990-11-14
AU624331B2 (en) 1992-06-11
PH26284A (en) 1992-04-10
YU109289A (en) 1991-08-31
ZA893382B (en) 1991-01-30
HUT54060A (en) 1991-01-28
HU204710B (en) 1992-02-28
BG91270A (bg) 1993-12-24
BG60544B1 (en) 1995-08-28
JPH03504121A (ja) 1991-09-12
CS318089A3 (en) 1992-05-13
US6099835A (en) 2000-08-08
IL90092A (en) 1995-03-30
CS277030B6 (en) 1992-11-18
WO1989011294A1 (en) 1989-11-30
EP0380484B1 (en) 1993-08-18
EP0380484A1 (en) 1990-08-08
CA1335425C (en) 1995-05-02
FI900412A0 (fi) 1990-01-25
DK16890A (da) 1990-01-22
ATE93143T1 (de) 1993-09-15
DK16890D0 (da) 1990-01-22
US5466449A (en) 1995-11-14
OA09785A (en) 1994-04-15
AU1940888A (en) 1989-12-12
LV10054B (en) 1995-02-20
MA21560A1 (fr) 1989-12-31
HU883981D0 (en) 1990-12-28
US5200182A (en) 1993-04-06
LV10054A (lv) 1994-05-10
RU2092183C1 (ru) 1997-10-10

Similar Documents

Publication Publication Date Title
HK42394A (en) Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
CA2212537A1 (en) Therapeutic inhibitor of vascular smooth muscle cells
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
EP0813409A4 (en) TREATMENT OF DISEASES CAUSED BY THE CYTOKIN GROWTH FACTOR
AU3329293A (en) Method of imparting antimicrobial activity to an ophthalmic composition
AU2840889A (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
CA2079171A1 (en) Cyclohexapeptidyl propanolamine compounds
AU5643299A (en) Humic acid and its use in the treatment of various conditions
IL145722A0 (en) Pharmaceutical composition comprising growth hormone and interferon
MY106984A (en) Antiviral or antibacterial composition and method of use.
AU591017B2 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
GR1001006B (el) Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων.
CA2097878A1 (en) Therapeutic agent for neutropenia
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
MX9307639A (es) Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido.
MY104932A (en) Immunomodulatory azaspiranes
AU2582588A (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)